192 related articles for article (PubMed ID: 18410593)
1. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
2. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
Tang SY; Monslow J; R Grant G; Todd L; Pawelzik SC; Chen L; Lawson J; Puré E; FitzGerald GA
Circulation; 2016 Jul; 134(4):328-38. PubMed ID: 27440004
[TBL] [Abstract][Full Text] [Related]
4. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
5. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
Koeberle A; Werz O
Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
[TBL] [Abstract][Full Text] [Related]
6. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
7. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.
Bahia MS; Katare YK; Silakari O; Vyas B; Silakari P
Med Res Rev; 2014 Jul; 34(4):825-55. PubMed ID: 25019142
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 derived PGE2 and PGI2 play an important role via EP2 and PPARdelta receptors in early steps of oil induced decidualization in mice.
Pakrasi PL; Jain AK
Placenta; 2008 Jun; 29(6):523-30. PubMed ID: 18407349
[TBL] [Abstract][Full Text] [Related]
10. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
Jachak SM
Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
Martin EM; Jones SL
Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
[TBL] [Abstract][Full Text] [Related]
12. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Puré E; FitzGerald GA
Circulation; 2008 Mar; 117(10):1302-9. PubMed ID: 18285567
[TBL] [Abstract][Full Text] [Related]
13. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
[TBL] [Abstract][Full Text] [Related]
14. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular biology of microsomal prostaglandin E synthase-1.
Wang M; FitzGerald GA
Trends Cardiovasc Med; 2010 Aug; 20(6):189-95. PubMed ID: 22137640
[TBL] [Abstract][Full Text] [Related]
16. Membrane prostaglandin E synthase-1: a novel therapeutic target.
Samuelsson B; Morgenstern R; Jakobsson PJ
Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
[TBL] [Abstract][Full Text] [Related]
17. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
[TBL] [Abstract][Full Text] [Related]
20. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]